BBP-418

· ML Bio Solutions, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BBP-418, covering 2025-05-08 to 2025-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of BBP-418 in Patients With LGMD2I [Phase 2]